Last Updated: May 3, 2026

bacitracin zinc; neomycin sulfate; polymyxin b sulfate - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for bacitracin zinc; neomycin sulfate; polymyxin b sulfate and what is the scope of patent protection?

Bacitracin zinc; neomycin sulfate; polymyxin b sulfate is the generic ingredient in five branded drugs marketed by Pharmafair, Pharmaderm, Casper Pharma Llc, Dow Pharm, Bausch And Lomb, Padagis Us, Sciegen Pharms, and Naska, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

Summary for bacitracin zinc; neomycin sulfate; polymyxin b sulfate
US Patents:0
Tradenames:5
Applicants:8
NDAs:8

US Patents and Regulatory Information for bacitracin zinc; neomycin sulfate; polymyxin b sulfate

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062386-001 Sep 9, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharmaderm BACITRACIN-NEOMYCIN-POLYMYXIN bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062167-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Casper Pharma Llc LUMI-SPORYN bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 050417-001 Approved Prior to Jan 1, 1982 AT RX Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Dow Pharm NEO-POLYCIN bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060647-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bausch And Lomb NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 064064-001 Oct 30, 1995 AT RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Padagis Us NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060764-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sciegen Pharms NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 065088-001 Feb 6, 2004 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links